News, Updates and Opinion

I regularly post about:

  • the business aspects of running a successful and profitable healthcare clinic

  • my educational and training activities

  • updates on treating veins

I hope they interest you and that the information benefits you in your practice.

I am always delighted to receive your comments or opinions, please get in touch.

  • Yesterday

The 5 Interlocking Systems of a Profitable Vein Clinic: Why Technical Mastery Alone Is Not Enough

Most healthcare practitioners concentrate on clinical operations while neglecting the commercial systems required to sustain a private practice. Consultant Vascular Specialist Dr Haroun Gajraj breaks down the five interdependent systems of a thriving vein clinic—Content, Marketing, Sales, Operations, and Customer Care—and explains why treating your practice like a modern media publisher is the key to predictable growth
Inadvertent injection of sclerosant into an artery. How to mitigate this disastrous complication

  • Sep 16

Inadvertent Intra-Arterial Injection of Sclerosants: Primary Evidence, Bedside Prevention, and Clinical Governance

  • Haroun Gajraj

An evidence-based analysis of inadvertent intra-arterial sclerosant injection, reviewing five decades of literature behind the 2024 Parsi et al. consensus guideline. Consultant Vascular Surgeon Haroun Gajraj examines why duplex ultrasound competence is the core determinant of safety, distinguishes true arterial injection from VAR-VAS, outlines immediate bedside emergency management, and addresses key UK medicolegal consent standards under Montgomery.
Clinician performing microsclerotherapy on leg spider veins under a magnifying lamp with overlaid text: "The Best Sclerosant Leg Spider Veins Polidocanol or STS?"

  • Sep 9

Polidocanol vs STS for Leg Telangiectasia: What Does the Evidence Actually Say?

  • Haroun Gajraj

Polidocanol (Aethoxysklerol) or STS (Fibrovein): which sclerosant is best for leg telangiectasia? Vascular specialist Haroun Gajraj breaks down the clinical evidence, dissects the EASI trial, and explains how to choose the right agent for spider vein microsclerotherapy.
VeinCare Academy branded graphic on a dark navy background. Headline reads 'Leaving the NHS for Private Practice?' with 'NHS' highlighted in a blue box. Below, five bullet points: no UK study shows one private practice model is best; CQC registration is a legal duty, not paperwork for later; doctors (GMC) and nurses (NMC) share the same honesty duties; three routes in — your own clinic, privileges, or a chain; 'busy' and 'profitable' are not the same thing. Text at the bottom reads 'Full article on the VeinCare Academy blog — link in comments' with a pointing-down emoji. Dr Haroun Gajraj, bald with glasses and wearing a navy polo shirt, gestures with both hands, positioned in the bottom right of the graphic.

  • Sep 2

Leaving the NHS for Private Practice: A Clinician’s Guide to UK Law, CQC, and Governance

  • Haroun Gajraj

Leaving the NHS for private practice is less about finding a secret business playbook and more about navigating strict UK legal and regulatory requirements. From mandatory CQC registration under the Health and Social Care Act 2008 to core GMC/NMC professional duties, dual-practice disclosure, and practice cash flow, here is what doctors and nurses actually need to know before stepping outside NHS employment
Dr Haroun Gajraj and medical practitioners participating in hands-on microsclerotherapy training for leg spider veins at VeinCare Academy.

  • Aug 26

Microsclerotherapy Injection Technique: The 5-Step Protocol for Spider Veins

Master safe and effective spider vein treatment with the refined "Low, Slow, Low, Low, Hold" protocol. Learn the critical seconds at the needle tip, how to read vessel blanching, and how to prevent matting and bleb formation.

  • Aug 19

Is Investing Heavily in CLaCS a Calculated Clinical Decision—or a Gamble?

CLaCS is visually compelling, technically sophisticated, and backed by emerging 2026 data showing reduced bruising and matting. But impressive technology isn't automatically a sound investment. Before committing significant capital to laser platforms, discover how the latest clinical evidence stacks up against real-world practice economics—and why meticulous injection fundamentals still matter most.
CLaCS vs Microsclerotherapy blog featured graphic showing three clinical views of cryo-laser and augmented reality vein visualization on a patient's leg, titled "What the 2026 Evidence Really Shows" by Dr Haroun Gajraj

  • Aug 12

CLaCS vs Microsclerotherapy: What the 2026 Evidence Really Shows

A clinical evidence review of cryo-laser and cryo-sclerotherapy (CLaCS) for leg telangiectasia and reticular veins. Based on a 2026 meta-analysis, this article examines what the pooled data proves regarding matting, microthrombi, and ecchymosis—and why vessel clearance and post-sclerotherapy pigmentation remain unproven. Read Dr. Haroun Gajraj’s detailed analysis for UK vein practices evaluating CLaCS vs. microsclerotherapy.
Graphic titled "How to Choose a Microsclerotherapy Training Course in the UK: A practical checklist for doctors, nurses and aesthetic practitioners" by Dr Haroun Gajraj | VeinCare Academy.

  • Aug 5

Best Microsclerotherapy Training Courses in the UK: 2026 Comparison & BAS Standards Guide

An independent 2026 review of UK microsclerotherapy training providers evaluated against the British Association of Sclerotherapists (BAS) draft standards. Explore a complete breakdown of active course providers across five categories—from regulated medical-only courses with named trainers to non-medical entry and theory modules. Learn how entry requirements, trainer patient volumes, CQC venue status, and practical assessments vary across the market before booking your training
Post-sclerotherapy pigmentation prevention and management strategies

  • Jul 29

Preventing and Managing Post-Sclerotherapy Pigmentation (Brown Staining): Evidence-Based Algorithm

  • Haroun Gajraj

An evidence-based clinical guide to post-sclerotherapy pigmentation (PSP). Review risk factors, 6 prevention strategies, and a staged management algorithm.
Featured header graphic titled "Topical Agents for Post-Sclerotherapy Pigmentation" with a patient quote box reading '"What cream will get rid of this?"'. The graphic features a clinical photograph of a leg showing post-sclerotherapy brown staining and hyperpigmentation following spider vein treatment. VeinCare Academy article header.

  • Jul 22

Topical Agents for Post-Sclerotherapy Pigmentation: What the Evidence Supports

Topical agents for post-sclerotherapy pigmentation: a clinical review.
The ankle is a bad place to start learning Microsclerotherapy.

  • Jul 15

Why the Ankle is a Bad Place to Start Learning Microsclerotherapy

This review is written for healthcare professionals learning Microsclerotherapy for leg telangiectasia. It looks at spider veins around the ankle, why this site behaves differently from the rest of the leg, and why it is a poor place for a beginner to start injecting.

  • Jul 8

How to Choose the Right Needle for Radiofrequency Thermocoagulation: A Clinician’s Guide

Which Needle for Radiofrequency Thermocoagulation? A Practical Guide for Clinicians | VeinCare Academy Meta description: A practical clinical guide to electrolysis needle selection for radiofrequency thermocoagulation of facial and leg telangiectasia, covering probe anatomy, shaft sizing, insulation rationale, and the evidence behind common practice recommendations.

Let's Keep In Touch!

Never Miss a Blog or News Item; Sent Directly to Your Email Inbox. Your email will never be shared.

Your email is safe with me.

You're signing up to receive emails from The VeinCare Academy. If you change your mind, you can unsubscribe with one click